Balchem Corporation (FRA:BL9B)
Germany
· Delayed Price · Currency is EUR 133.00
+0.90 (0.68%)
Last updated: Dec 5, 2025, 1:01 PM CET
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| United States Revenue | 752.02M | 723.30M |
Log In |
Log In |
Log In | Upgrade
|
| Foreign Countries Revenue | 261.52M | 230.38M |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 1.01B | 953.68M |
Log In |
Log In |
Log In | Upgrade
|
Revenue Breakdown
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| Human Nutrition and Health Revenue | 640.62M | 600.26M |
Log In |
Log In |
Log In | Upgrade
|
| Animal Nutrition and Health Revenue | 228.01M | 214.71M |
Log In |
Log In |
Log In | Upgrade
|
| Specialty Products Revenue | 138.99M | 132.75M |
Log In |
Log In |
Log In | Upgrade
|
| Other and Unallocated Business Segment Revenue | 5.93M | 5.97M |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 1.01B | 953.68M |
Log In |
Log In |
Log In | Upgrade
|
Revenue Breakdown 2
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| Product Sales Revenue | 1.01B | 951.95M |
Log In |
Log In |
Log In | Upgrade
|
| Royalty Revenue | 1.80M | 1.74M |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 1.01B | 953.68M |
Log In |
Log In |
Log In | Upgrade
|
EBIT
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| Human Nutrition and Health Earnings From Operations | 150.90M | 135.96M |
Log In |
Log In |
Log In | Upgrade
|
| Animal Nutrition and Health Earnings From Operations | 18.19M | 14.01M |
Log In |
Log In |
Log In | Upgrade
|
| Specialty Products Earnings From Operations | 42.35M | 39.91M |
Log In |
Log In |
Log In | Upgrade
|
| Other and Unallocated Business Segment Earnings From Operations | -6.97M | -6.97M |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Total) | 204.48M | 182.91M |
Log In |
Log In |
Log In | Upgrade
|
Key Performance Indicators
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2012 - 2019 |
| Human Nutrition and Health Backlog | 39.96B |
Log In |
Log In |
Log In | Upgrade
|
| Animal Nutrition and Health Backlog | 9.04B |
Log In |
Log In |
Log In | Upgrade
|
| Specialty Products Backlog | 1.28B |
Log In |
Log In |
Log In | Upgrade
|
| Other Business Segment Backlog | 137.00M |
Log In |
Log In |
Log In | Upgrade
|
| Total Backlog | 50.42B |
Log In |
Log In |
Log In | Upgrade
|